{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:11:14Z","timestamp":1787220674635,"version":"build-2736575974"},"reference-count":105,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":287,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL122267"],"award-info":[{"award-number":["R01 HL122267"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK089502"],"award-info":[{"award-number":["P30DK089502"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["238G19a"],"award-info":[{"award-number":["238G19a"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1074\/jbc.ra119.010320","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T23:58:24Z","timestamp":1569887904000},"page":"17090-17104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"294","author":[{"given":"Murali K.","family":"Yanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoung","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina V.","family":"Cebotaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila","family":"Cebotaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.010320_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.pap.0000163959.29032.1f","article-title":"Molecular basis of autosomal dominant polycystic kidney disease","volume":"12","author":"Al-Bhalal","year":"2005","journal-title":"Adv. Anat. Pathol"},{"key":"10.1074\/jbc.RA119.010320_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/snep.2001.20929","article-title":"The genetics and physiology of polycystic kidney disease","volume":"21","author":"Calvet","year":"2001","journal-title":"Semin. Nephrol"},{"key":"10.1074\/jbc.RA119.010320_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/hmg\/4.4.575","article-title":"Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium)","volume":"4","author":"Burn","year":"1995","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA119.010320_bib4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.010320_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.mnh.0000232888.65895.e7","article-title":"Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy","volume":"15","author":"Harris","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1074\/jbc.RA119.010320_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA119.010320_bib7","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1681\/ASN.V10112412","article-title":"Acute regulation of proximal tubule apical membrane Na\/H exchanger NHE-3: role of phosphorylation, protein trafficking, and regulatory factors","volume":"10","author":"Moe","year":"1999","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA119.010320_bib8","first-page":"G571","article-title":"Molecular biology of Na+ absorption","volume":"273","author":"Barbry","year":"1997","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib9","series-title":"Renal Physiology E-Book: Mosby Physiology Monograph Series","author":"Koeppen","year":"2012"},{"key":"10.1074\/jbc.RA119.010320_bib10","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.1987.121","article-title":"Cyst formation and growth in autosomal dominant polycystic kidney disease","volume":"31","author":"Grantham","year":"1987","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.RA119.010320_bib11","doi-asserted-by":"crossref","first-page":"C1179","DOI":"10.1152\/ajpcell.1998.275.5.C1179","article-title":"Can ENaC regulate ICF as well as ECF volume? Focus on \u201cosmotic pressure regulates \u03b1\u03b2\u03b3-rENaC expressed in Xenopus oocytes\u201d (editorial; comment)","volume":"275","author":"McDonough","year":"1998","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1165\/ajrcmb.20.3.3283","article-title":"Quantitation and localization of ENaC subunit expression in fetal, newborn, and adult mouse lung","volume":"20","author":"Talbot","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"10.1074\/jbc.RA119.010320_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00424-002-0959-x","article-title":"Functional interaction of CFTR and ENaC in sweat glands","volume":"445","author":"Reddy","year":"2003","journal-title":"Pflugers Arch"},{"key":"10.1074\/jbc.RA119.010320_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev.physiol.62.1.573","article-title":"Structure and regulation of amiloride-sensitive sodium channels","volume":"62","author":"Alvarez de la Rosa","year":"2000","journal-title":"Annu. Rev. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib15","doi-asserted-by":"crossref","first-page":"F917","DOI":"10.1152\/ajprenal.00616.2011","article-title":"Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion","volume":"302","author":"Graffe","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coph.2013.11.010","article-title":"Epithelial sodium channel (ENaC) and the control of blood pressure","volume":"15","author":"Rossier","year":"2014","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1074\/jbc.RA119.010320_bib17","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.96.5.2514","article-title":"Epithelial sodium channel regulated by aldosterone-induced protein sgk","volume":"96","author":"Chen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010320_bib18","doi-asserted-by":"crossref","first-page":"20207","DOI":"10.1074\/jbc.M611329200","article-title":"Nedd4-2 catalyzes ubiquitination and degradation of cell surface ENaC","volume":"282","author":"Zhou","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib19","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1038\/s41598-017-08284-4","article-title":"NEDD4-family E3 ligase dysfunction due to PKHD1\/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology","volume":"7","author":"Kaimori","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA119.010320_bib20","doi-asserted-by":"crossref","first-page":"F244","DOI":"10.1152\/ajprenal.00169.2003","article-title":"Decreased amiloride-sensitive Na+ absorption in collecting duct principal cells isolated from BPK ARPKD mice","volume":"286","author":"Veizis","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ebiom.2019.01.006","article-title":"Salt-deficient diet exacerbates cystogenesis in ARPKD via epithelial sodium channel (ENaC)","volume":"40","author":"Ilatovskaya","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1074\/jbc.RA119.010320_bib22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1074\/jbc.RA119.010320_bib23","doi-asserted-by":"crossref","first-page":"C267","DOI":"10.1152\/ajpcell.1992.263.2.C267","article-title":"Cftr!","volume":"263","author":"Fuller","year":"1992","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s004240100671","article-title":"Arginine vasopressin regulates CFTR and ClC-2 mRNA expression in rat kidney cortex and medulla","volume":"443","author":"Morales","year":"2001","journal-title":"Pflugers Arch"},{"key":"10.1074\/jbc.RA119.010320_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000095133","article-title":"A regulatory role of polycystin-1 on cystic fibrosis transmembrane conductance regulator plasma membrane expression","volume":"18","author":"Ikeda","year":"2006","journal-title":"Cell. Physiol. Biochem"},{"key":"10.1074\/jbc.RA119.010320_bib26","doi-asserted-by":"crossref","first-page":"C389","DOI":"10.1152\/ajpcell.1996.270.1.C389","article-title":"A role for CFTR in human autosomal dominant polycystic kidney disease","volume":"270","author":"Hanaoka","year":"1996","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.1998.78.4.1165","article-title":"Epithelial transport in polycystic kidney disease","volume":"78","author":"Sullivan","year":"1998","journal-title":"Physiol. Rev"},{"key":"10.1074\/jbc.RA119.010320_bib28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0272-6386(98)70072-1","article-title":"Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease","volume":"32","author":"O'Sullivan","year":"1998","journal-title":"Am. J. Kidney Dis"},{"key":"10.1074\/jbc.RA119.010320_bib29","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1681\/ASN.V11122285","article-title":"CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease","volume":"11","author":"Persu","year":"2000","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA119.010320_bib30","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1021\/jm9009873","article-title":"Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model","volume":"52","author":"Tradtrantip","year":"2009","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib31","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2174\/138161206777585148","article-title":"CFTR chloride channel drug discovery\u2013inhibitors as antidiarrheals and activators for therapy of cystic fibrosis","volume":"12","author":"Verkman","year":"2006","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.RA119.010320_bib32","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1681\/ASN.2007070828","article-title":"Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease","volume":"19","author":"Yang","year":"2008","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA119.010320_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/11313570-000000000-00000","article-title":"Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease","volume":"23","author":"Li","year":"2009","journal-title":"Biodrugs"},{"key":"10.1074\/jbc.RA119.010320_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.emboj.7600040","article-title":"Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator","volume":"23","author":"Lewis","year":"2004","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA119.010320_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"Riordan","year":"2008","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.RA119.010320_bib36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.010320_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0092-8674(95)90241-4","article-title":"Multiple proteolytic systems, including the proteasome, contribute to CFTR processing","volume":"83","author":"Jensen","year":"1995","journal-title":"Cell"},{"key":"10.1074\/jbc.RA119.010320_bib38","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective \u0394F508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA119.010320_bib39","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.010320_bib40","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.2174\/13816128113199990318","article-title":"Rescuing mutant CFTR: a multi-task approach to a better outcome in treating cystic fibrosis","volume":"19","author":"Amaral","year":"2013","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.RA119.010320_bib41","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010320_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2011-200393","article-title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation","volume":"67","author":"Clancy","year":"2012","journal-title":"Thorax"},{"key":"10.1074\/jbc.RA119.010320_bib43","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1074\/jbc.RA118.001846","article-title":"A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector","volume":"293","author":"Yanda","year":"2018","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nm.1865","article-title":"An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice","volume":"14","author":"Traykova-Brauch","year":"2008","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA119.010320_bib45","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1097\/01.ASN.0000144204.01352.86","article-title":"A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo","volume":"15","author":"Piontek","year":"2004","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA119.010320_bib46","doi-asserted-by":"crossref","first-page":"F1176","DOI":"10.1152\/ajprenal.00130.2012","article-title":"Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth","volume":"303","author":"Li","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.RA119.010320_bib48","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA119.010320_bib49","doi-asserted-by":"crossref","first-page":"F1038","DOI":"10.1152\/ajprenal.1996.270.6.F1038","article-title":"Both the wild type and a functional isoform of CFTR are expressed in kidney","volume":"270","author":"Morales","year":"1996","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib50","first-page":"F723","article-title":"Developmental regulation of CFTR expression during human nephrogenesis","volume":"271","author":"Devuyst","year":"1996","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.1253","article-title":"Mechanism-based corrector combination restores \u0394F508-CFTR folding and function","volume":"9","author":"Okiyoneda","year":"2013","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.RA119.010320_bib52","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.M117.803775","article-title":"Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease","volume":"292","author":"Yanda","year":"2017","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib53","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00186.2017","article-title":"An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease","volume":"313","author":"Yanda","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.149.1.111","article-title":"Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells","volume":"149","author":"Charron","year":"2000","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.RA119.010320_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jcs.226886","article-title":"Transcytosis maintains CFTR apical polarity in the face of constitutive and mutation-induced basolateral missorting","volume":"132","author":"Bidaud-Meynard","year":"2019","journal-title":"J. Cell Sci"},{"key":"10.1074\/jbc.RA119.010320_bib56","doi-asserted-by":"crossref","first-page":"F283","DOI":"10.1152\/ajprenal.2001.280.2.F283","article-title":"NHE3 activity and trafficking depend on the state of actin organization in proximal tubule","volume":"280","author":"Chalumeau","year":"2001","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib57","doi-asserted-by":"crossref","first-page":"16494","DOI":"10.1074\/jbc.M300580200","article-title":"Lysophosphatidic acid stimulates brush border Na+\/H+ exchanger 3 (NHE3) activity by increasing its exocytosis by an NHE3 kinase A regulatory protein-dependent mechanism","volume":"278","author":"Lee-Kwon","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib58","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1093\/hmg\/ddv367","article-title":"Reduced sodium\/proton exchanger NHE3 activity causes congenital sodium diarrhea","volume":"24","author":"Janecke","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA119.010320_bib59","doi-asserted-by":"crossref","first-page":"26329","DOI":"10.1074\/jbc.M601373200","article-title":"The polycystin 1\u2013C-terminal fragment stimulates ERK-dependent spreading of renal epithelial cells","volume":"281","author":"Joly","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib60","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ki.2008.395","article-title":"Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo","volume":"74","author":"Wei","year":"2008","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.RA119.010320_bib61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1085\/jgp.200308979","article-title":"Inhibition and redistribution of NHE3, the apical Na+\/H+ exchanger, by Clostridium difficile toxin B","volume":"123","author":"Hayashi","year":"2004","journal-title":"J. Gen. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib62","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s004240050704","article-title":"S3226, a novel inhibitor of Na+\/H+ exchanger subtype 3 in various cell types","volume":"436","author":"Schwark","year":"1998","journal-title":"Pflugers Arch"},{"key":"10.1074\/jbc.RA119.010320_bib63","doi-asserted-by":"crossref","first-page":"F375","DOI":"10.1152\/ajprenal.2000.278.3.F375","article-title":"Role of Na+\/H+ exchanger NHE3 in nephron function: micropuncture studies with S3226, an inhibitor of NHE3","volume":"278","author":"Vallon","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib64","first-page":"72A","article-title":"Tenapanor, a minimally absorbed NHE3 inhibitor, reduces dietary phosphorus absorption in healthy volunteers","volume":"25","author":"Rosenbaum","year":"2014","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA119.010320_bib65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10157-016-1302-8","article-title":"A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers","volume":"21","author":"Johansson","year":"2017","journal-title":"Clin. Exp. Nephrol"},{"key":"10.1074\/jbc.RA119.010320_bib66","doi-asserted-by":"crossref","first-page":"a029140","DOI":"10.1101\/cshperspect.a029140","article-title":"Adherens junctions on the move-membrane trafficking of E-cadherin","volume":"9","author":"Br\u00fcser","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1074\/jbc.RA119.010320_bib67","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mam.2012.05.001","article-title":"SLC9\/NHE gene family, a plasma membrane and organellar family of Na+\/H+ exchangers","volume":"34","author":"Donowitz","year":"2013","journal-title":"Mol. Aspects Med"},{"key":"10.1074\/jbc.RA119.010320_bib68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tcb.2014.02.004","article-title":"Orchestration of cell surface proteins by Rab11","volume":"24","author":"Welz","year":"2014","journal-title":"Trends Cell Biol"},{"key":"10.1074\/jbc.RA119.010320_bib69","doi-asserted-by":"crossref","first-page":"C600","DOI":"10.1152\/ajpcell.1996.270.2.C600","article-title":"Chronic regulation of transepithelial Na+ transport by the rate of apical Na+ entry","volume":"270","author":"Rokaw","year":"1996","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00424-008-0595-1","article-title":"Luminal Na+\/H+ exchange in the proximal tubule","volume":"458","author":"Bobulescu","year":"2009","journal-title":"Pflugers Arch"},{"key":"10.1074\/jbc.RA119.010320_bib71","first-page":"45","article-title":"Cl\u2212 permeability of sweat duct cell membranes: intracellular microelectrode analysis","volume":"254","author":"Reddy","year":"1987","journal-title":"Prog. Clin. Biol. Res"},{"key":"10.1074\/jbc.RA119.010320_bib72","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1152\/physrev.1999.79.1.S3","article-title":"Physiological basis of cystic fibrosis: a historical perspective","volume":"79","author":"Quinton","year":"1999","journal-title":"Physiol. Rev"},{"key":"10.1074\/jbc.RA119.010320_bib73","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI7453","article-title":"A PDZ-interacting domain in CFTR is an apical membrane polarization signal","volume":"104","author":"Moyer","year":"1999","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA119.010320_bib74","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1242\/jcs.114.4.719","article-title":"A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane","volume":"114","author":"Milewski","year":"2001","journal-title":"J. Cell Sci"},{"key":"10.1074\/jbc.RA119.010320_bib75","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.resp.2007.06.005","article-title":"Liquid movement across the surface epithelium of large airways","volume":"159","author":"Chambers","year":"2007","journal-title":"Respir. Physiol. Neurobiol"},{"key":"10.1074\/jbc.RA119.010320_bib76","doi-asserted-by":"crossref","first-page":"L1123","DOI":"10.1152\/ajplung.00049.2005","article-title":"Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl\u2212 transport and overexpression can generate basolateral CFTR","volume":"289","author":"Farmen","year":"2005","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib77","doi-asserted-by":"crossref","first-page":"40099","DOI":"10.1074\/jbc.M206964200","article-title":"PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator","volume":"277","author":"Swiatecka-Urban","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib78","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1749-6632.1989.tb25182.x","article-title":"Cl\u2212 conductance and acid secretion in the human sweat duct","volume":"574","author":"Quinton","year":"1989","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1074\/jbc.RA119.010320_bib79","doi-asserted-by":"crossref","first-page":"C727","DOI":"10.1152\/ajpcell.1989.257.4.C727","article-title":"Localization of Cl\u2212 conductance in normal and Cl\u2212 impermeability in cystic fibrosis sweat duct epithelium","volume":"257","author":"Reddy","year":"1989","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib80","doi-asserted-by":"crossref","first-page":"11709","DOI":"10.1074\/jbc.M111958200","article-title":"A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator","volume":"277","author":"Gelman","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib81","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1358\/dot.2016.52.4.2467205","article-title":"Lumacaftor\/ivacaftor combination for CF patients homozygous for Phe508del-CFTR","volume":"52","author":"Zhang","year":"2016","journal-title":"Drugs Today"},{"key":"10.1074\/jbc.RA119.010320_bib82","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1807119","article-title":"VX-659-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Davies","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.010320_bib83","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013tezacaftor\u2013ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.010320_bib84","doi-asserted-by":"crossref","first-page":"F896","DOI":"10.1152\/ajprenal.00160.2004","article-title":"Differential traffic of proximal tubule Na+ transporters during hypertension or PTH: NHE3 to base of microvilli vs. NaPi2 to endosomes","volume":"287","author":"Yang","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib85","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1074\/jbc.273.4.2035","article-title":"The epithelial sodium-hydrogen antiporter Na+\/H+ exchanger 3 accumulates and is functional in recycling endosomes","volume":"273","author":"D'Souza","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib86","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1091\/mbc.e05-09-0843","article-title":"The NHE3 juxtamembrane cytoplasmic domain directly binds ezrin: dual role in NHE3 trafficking and mobility in the brush border","volume":"17","author":"Cha","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.RA119.010320_bib87","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1073\/pnas.94.7.3010","article-title":"cAMP-mediated inhibition of the epithelial brush border Na+\/H+ exchanger, NHE3, requires an associated regulatory protein","volume":"94","author":"Yun","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010320_bib88","doi-asserted-by":"crossref","first-page":"C1527","DOI":"10.1152\/ajpcell.00017.2003","article-title":"Ca2+-dependent inhibition of NHE3 requires PKC\u03b1 which binds to E3KARP to decrease surface NHE3 containing plasma membrane complexes","volume":"285","author":"Lee-Kwon","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib89","doi-asserted-by":"crossref","first-page":"23714","DOI":"10.1074\/jbc.M200835200","article-title":"Ca2+-dependent inhibition of Na+\/H+ exchanger 3 (NHE3) requires an NHE3\u2013E3KARP\u2013\u03b1-actinin-4 complex for oligomerization and endocytosis","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib90","first-page":"203","article-title":"Coordination of pancreatic HCO3\u2212 secretion by protein\u2013protein interaction between membrane transporters","volume":"2","author":"Lee","year":"2001","journal-title":"JOP"},{"key":"10.1074\/jbc.RA119.010320_bib91","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbrc.2006.06.112","article-title":"NHE3 inhibits PKA-dependent functional expression of CFTR by NHERF2 PDZ interactions","volume":"347","author":"Favia","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.RA119.010320_bib92","doi-asserted-by":"crossref","first-page":"21480","DOI":"10.1074\/jbc.M112245200","article-title":"Reciprocal protein kinase A regulatory interactions between cystic fibrosis transmembrane conductance regulator and Na+\/H+ exchanger isoform 3 in a renal polarized epithelial cell model","volume":"277","author":"Bagorda","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib93","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.physiol.67.032003.154107","article-title":"Assembly of functional CFTR chloride channels","volume":"67","author":"Riordan","year":"2005","journal-title":"Annu. Rev. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib94","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1091\/mbc.e09-11-0944","article-title":"The endoplasmic reticulum\u2013associated degradation of the epithelial sodium channel requires a unique complement of molecular chaperones","volume":"21","author":"Buck","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.RA119.010320_bib95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/JMN:23:1-2:041","article-title":"CFTR and chaperones: processing and degradation","volume":"23","author":"Amaral","year":"2004","journal-title":"J. Mol. Neurosci"},{"key":"10.1074\/jbc.RA119.010320_bib96","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/emboj\/18.6.1492","article-title":"The Hdj-2\/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis","volume":"18","author":"Meacham","year":"1999","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA119.010320_bib97","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1093\/emboj\/17.23.6879","article-title":"Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome","volume":"17","author":"Loo","year":"1998","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA119.010320_bib98","doi-asserted-by":"crossref","first-page":"25636","DOI":"10.1074\/jbc.M115.671925","article-title":"Combination of correctors rescue \u0394F508-CFTR by reducing its association with Hsp40 and Hsp27","volume":"290","author":"Lopes-Pacheco","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010320_bib99","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1073\/pnas.0507903103","article-title":"Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels","volume":"103","author":"Goldfarb","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010320_bib100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/bj20011717","article-title":"The human DnaJ homologue (Hdj)-1\/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70","volume":"366","author":"Farinha","year":"2002","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.RA119.010320_bib101","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.physiol.64.081501.155819","article-title":"Molecular chaperones in the kidney","volume":"64","author":"Borkan","year":"2002","journal-title":"Annu. Rev. Physiol"},{"key":"10.1074\/jbc.RA119.010320_bib102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12192-009-0141-x","article-title":"Versatility of the small heat shock protein HSPB6 (Hsp20)","volume":"15","author":"Seit-Nebi","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"10.1074\/jbc.RA119.010320_bib103","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.bbadis.2011.05.008","article-title":"Apico-basal polarity in polycystic kidney disease epithelia","volume":"1812","author":"Wilson","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA119.010320_bib104","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease","volume":"45","author":"Ma","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.RA119.010320_bib105","doi-asserted-by":"crossref","first-page":"13716","DOI":"10.1074\/jbc.270.23.13716","article-title":"Separate C-terminal domains of the epithelial specific brush border Na+\/H+ exchanger isoform NHE3 are involved in stimulation and inhibition by protein kinases\/growth factors","volume":"270","author":"Levine","year":"1995","journal-title":"J. Biol. Chem"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820305469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820305469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.010320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T07:52:07Z","timestamp":1721807527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820305469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":105,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0021925820305469"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.010320","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.010320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Yanda et al.","name":"copyright","label":"Copyright"}]}}